Paula
Rodríguez Otero
Consultora Médica
Helsinki University Central Hospital
Helsinki, FinlandiaPublicaciones en colaboración con investigadores/as de Helsinki University Central Hospital (1)
2020
-
Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
Leukemia and Lymphoma, Vol. 61, Núm. 8, pp. 1850-1859